Literature DB >> 10362552

Induction of apoptosis by overexpression of the DNA-binding and DNA-PK-activating protein C1D.

K Rothbarth1, E Spiess, B Juodka, U Yavuzer, P Nehls, H Stammer, D Werner.   

Abstract

Apoptosis is induced in various tumor cell lines by vector-dependent overexpression of the conserved gene C1D that encodes a DNA-binding and DNA-PK-activating protein. C1D is physiologically expressed in 50 human tissues tested, which points to its basic cellular function. The expression of this gene must be tightly regulated because elevated levels of C1D protein, e.g. those induced by transient vector-dependent expression, result in apoptotic cell death. Cells transfected with C1D-expressing constructs show terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling of DNA ends. Transfections with constructs in which C1D is expressed in fusion with the (enhanced) green fluorescent protein from A. victoria (EGFP) allow the transfected cells to be identified and the morphological changes induced to be traced. Starting from intense nuclear spots, green fluorescence reflecting C1D expression increases dramatically at 12-24 hours post-transfection. Expression of C1D-EGFP protein is accompanied by morphological changes typical of apoptotic cell death, e.g. cytoplasmic vacuolation, membrane blebbing and nuclear disintegration. Cell shrinkage and detachment from extracellular matrix are observed in monolayer cultures while suspension cells become progressively flattened. The facility to differentiate between transfected and non-transfected cells reveals that non-transfected cells co-cultured with transfected cells also show the morphological changes of apoptosis, which points to a bystander effect. C1D-dependent apoptosis is not induced in cells with non-functional p53. Accordingly, C1D-induced apoptosis is discussed in relation to its potential to activate DNA-PK, which has been considered to act as an upstream activator of p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362552     DOI: 10.1242/jcs.112.13.2223

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  XPB induces C1D expression to counteract UV-induced apoptosis.

Authors:  Guang Li; Juhong Liu; Mones Abu-Asab; Shibuya Masabumi; Yoshiro Maru
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.

Authors:  Eiji Sakashita; Sawako Tatsumi; Dieter Werner; Hitoshi Endo; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Assembly of the yeast exoribonuclease Rrp6 with its associated cofactor Rrp47 occurs in the nucleus and is critical for the controlled expression of Rrp47.

Authors:  Monika Feigenbutz; Rebecca Jones; Tabot M D Besong; Stephen E Harding; Phil Mitchell
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

4.  The leucine rich region of DNA-PKcs contributes to its innate DNA affinity.

Authors:  Shikha Gupta; Katheryn Meek
Journal:  Nucleic Acids Res       Date:  2005-12-09       Impact factor: 16.971

5.  Proteasome-mediated degradation antagonizes critical levels of the apoptosis-inducing C1D protein.

Authors:  Karsten Rothbarth; Hermann Stammer; Dieter Werner
Journal:  Cancer Cell Int       Date:  2002-09-02       Impact factor: 5.722

6.  Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in circulating leukocytes of Caucasian males.

Authors:  Peter C Charles; Brian D Alder; Eleanor G Hilliard; Jonathan C Schisler; Robert E Lineberger; Joel S Parker; Sabeen Mapara; Samuel S Wu; Andrea Portbury; Cam Patterson; George A Stouffer
Journal:  BMC Med Genomics       Date:  2008-08-18       Impact factor: 3.063

Review 7.  C1D family proteins in coordinating RNA processing, chromosome condensation and DNA damage response.

Authors:  Rebecca A Jackson; Jocelyn Shumei Wu; Ee Sin Chen
Journal:  Cell Div       Date:  2016-03-09       Impact factor: 5.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.